“Minor cannabinoids and their chemical homologs offer the potential medicinal benefits of Δ9-THC without adverse effects,” the study’s authors concluded.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
#1: Legislatures in five states enacted adult-use legalization laws in 2021 marking a significant change from past years when similar laws were enacted almost exclusively via citizens’ initiatives.
“We have never seen such dramatic decreases in drug use among teens in just a one-year period,” said Nora Volkow, Director of the US National Institute on Drug Abuse, which funded the study.
Based on the study’s findings, investigators concluded, “Using lower doses of CBD and trace THC seems to be promising in managing behavioral problems associated with autism.”
A supermajority of US physicians say that cannabis is medicinal, and over one-quarter have recommended it to their patients.
Case Series: Whole-Plant Cannabis Extracts Effective in Pediatric Patients with Intractable Epilepsy
“Our data suggest that whole-plant medical cannabis products are superior to isolated CBD products in the patients examined,” investigators reported.
Refusing to hear this case only prolongs the conflicts that currently exist between state laws and federal marijuana laws, NORML’s brief argues.
Scientists concluded, “Our novel findings support the possible therapeutic role of inhaled CBD as an effective, relatively safe, and easy to administer treatment adjunct for GBM.”